| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |